Pressure to deliver quarterly returns can drive managerial myopia. Recent studies link the short-termism to Wall Street culture and dynamics. But a deeper analysis tells a different story.
Stock buybacks have found themselves in various crosshairs of late, and it’s got Maryland Smith’s David Kass shaking his head. Buybacks, he says, are not the problem.
The crisis over tainted heart drugs made in China and sold in the U.S. had an oddly familiar ring to it for Maryland Smith’s Clifford Rossi. But it wasn’t a previous medical drug crisis that crept to mind for him.
As the federal shutdown continues, now well past 30 days, its effects are spreading ever wider, Maryland Smith's Elinda F. Kiss writes. Here is what it looks like now.
There was a key development on Capitol Hill last week you might have missed. The decades-old Gephardt Rule, which seeks to avoid having the U.S. run afoul of the debt limit, was given new life.
“A New Year’s Resolution is a promise to yourself,” Maryland Smith’s Elinda F. Kiss says. Here's how to make a financial resolution and make it stick.
Like the big man in the North Pole, Maryland Smith’s David Kass spends the waning weeks of the year making a list and checking it twice.
Maryland Smith faculty share their best travel hacks, from traveling early to the best ways to tolerate traffic, to make your holidays easier.
Pharmaceutical prices are poised to become a central issue for the next Congress, potentially forcing lawmakers to consider at least two factors that coincide with America’s higher-than-average drug prices.
The stock market was taking the election in stride, beginning a rally that could extend through next year. Maryland Smith's David Kass explains three reasons why.